Search results
Richard Alan Lerner (August 26, 1938 – December 2, 2021) was an American research chemist. He was best known for his work on catalytic antibodies and combinatorial antibody libraries.
Jan 6, 2022 · Richard Lerner, physician-scientist and president of Scripps Research from 1987 to 2012, died on 2 December 2021. He was 83. Richard had an enormous impact on science, both through his powerful intellect and creativity in the laboratory and as the bold, inspirational leader who grew Scripps Research into one of the world’s preeminent research ...
Apr 29, 2022 · Richard A. Lerner (1938-2021) was both a chemist and an MD. He investigated the structure of peptides and proteins, identified a sleep-inducing lipid, and is best known for his pioneering work on catalytic antibodies.
Dec 4, 2021 · LA JOLLA, CA—Richard Lerner, MD, a scientific pioneer who developed technologies that had a major impact on science and medicine, and who played a critical role in shaping Scripps Research and San Diego’s burgeoning life sciences sector, passed away on December 2, 2021. He was 83 years old.
Nov 28, 2023 · Richard Lerner was a singularity. During his tenure, Scripps Research was transformed into a biomedical powerhouse. He rapidly built remarkable strength in chemical and structural biology, immunology, cell and molecular biology, and molecular medicine.
Dec 7, 2021 · Richard Lerner, the masterful biochemist who helped build La Jolla’s Scripps Research Institute into an elite center for biomedical science and helped develop the breakthrough drugs Humira and...
Dec 7, 2021 · Richard Lerner, who played a significant role in shaping both Scripps Research and the San Diego life sciences ecosystem and developing AbbVie's blockbuster drug Humira, died Dec. 2. He was 83. Lerner served as director and president of Scripps Research from 1987 through 2012.
